Related Experiment Video

Updated: Feb 10, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.1K

PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders

G Luzzatto, F Fabris, M Mazzucato

    Scandinavian Journal of Haematology
    |September 1, 1985
    PubMed

    Insights

    Patients with myeloproliferative disorders (MPD) show increased platelet activation and earlier signs of aging. Platelet activation markers like beta-thromboglobulin are elevated in MPD, suggesting a higher thrombotic risk in some patients.

    Area of Science:

    • Hematology
    • Platelet Physiology
    • Thrombosis Research

    Background:

    • Platelet activation and release of factors like beta-thromboglobulin (beta TG) are associated with aging.
    • Myeloproliferative disorders (MPD) are a group of conditions affecting blood cell production.

    Purpose of the Study:

    • To investigate platelet activation in patients with myeloproliferative disorders (MPD).
    • To assess the impact of MPD on age-related changes in platelet function.
    • To evaluate the thrombotic risk associated with specific MPD subtypes.

    Main Methods:

    • Studied 19 patients with MPD and compared them to normal controls.
    • Measured beta-thromboglobulin (beta TG) and platelet factor 4 (PF 4) release.
    • Assessed thromboxane B2 (TxB2) production.
    • Evaluated the effects of aspirin plus dipyridamole and a coumarin derivative (AD 6) on platelet parameters.

    Main Results:

    • MPD patients exhibited greater beta TG release than controls, indicating increased platelet activation.
    • PF 4 levels were consistently low, suggesting in vitro activation artifacts.
    • TxB2 production was increased overall but varied with platelet count, with decreased levels in thrombocythemic patients indicating higher thrombotic risk.
    • Aspirin plus dipyridamole significantly reduced TxB2, while AD 6 had no effect on measured parameters.

    Conclusions:

    • MPD accelerates age-related platelet activation phenomena.
    • Elevated beta TG in MPD suggests increased platelet activation and potential thrombotic risk.
    • TxB2 levels correlate with thrombotic risk in MPD, and aspirin plus dipyridamole may mitigate this risk.

    More Related Videos

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets05:49

    Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

    Published on: November 29, 2024

    1.2K
    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    12.5K

    Related Concept Videos

    The Evidence for Evolution02:55

    The Evidence for Evolution

    Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
    48.4K
    Intrinsically Disordered Proteins02:18

    Intrinsically Disordered Proteins

    Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
    19.6K
    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
    3.7K
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    9.4K
    Dipeptidyl Peptidase 4 Inhibitors01:23

    Dipeptidyl Peptidase 4 Inhibitors

    Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
    687
    Bone Disorders01:29

    Bone Disorders

    Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
    Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
    5.4K